Protein Kinase Cι Drives a NOTCH3-dependent Stem-like Phenotype in Mutant KRAS Lung Adenocarcinoma

Syed A Ali1, Verline Justilien1, Lee Jamieson1

  • 1Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, FL 32224, USA.

Cancer Cell
|March 16, 2016
PubMed

Insights

Protein kinase Cι (PKCι) drives lung adenocarcinoma (LADC) by activating NOTCH3 expression via the ELF3 transcription factor. Targeting this PKCι-ELF3-NOTCH3 pathway shows promise for treating KRAS-mutated LADC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • KRAS-mediated lung adenocarcinoma (LADC) is a significant clinical challenge.
  • Tumor stemness and asymmetric cell division are critical for LADC initiation and maintenance.
  • The role of protein kinase Cι (PKCι) in LADC stemness is not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanism by which PKCι regulates stemness in LADC.
  • To investigate the role of the NOTCH3 pathway in PKCι-driven LADC.
  • To evaluate the therapeutic potential of targeting the PKCι-ELF3-NOTCH3 signaling axis.

Main Methods:

  • Investigated the interaction between PKCι, ELF3, and NOTCH3 in LADC cells.
  • Assessed ELF3 occupancy on the NOTCH3 promoter using chromatin immunoprecipitation assays.
  • Examined the effect of PKCι and NOTCH inhibition on asymmetric cell division and tumor growth in vitro and in vivo.

Main Results:

  • PKCι oncogene controls NOTCH3 expression, a key driver of stemness in KRAS-mutated LADC.
  • PKCι phosphorylates ELF3, enhancing its binding to the NOTCH3 promoter, thereby activating NOTCH3 expression.
  • PKCι-ELF3-NOTCH3 signaling regulates asymmetric cell division, crucial for tumor initiation and maintenance.
  • Combined blockade of PKCι and NOTCH synergistically inhibited LADC cell tumorigenicity and tumor growth.

Conclusions:

  • The PKCι-ELF3-NOTCH3 signaling pathway is a critical regulator of stemness and tumorigenesis in KRAS-mutated LADC.
  • Targeting this pathway offers a promising therapeutic strategy for KRAS LADC.
  • Pharmacologic inhibition of PKCι and NOTCH demonstrates significant therapeutic potential.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K